• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Bionomics Limited - Articles and news items

Bionomics initiates Phase II clinical study of BNC210 for the treatment of anxiety and depression

Industry news / 22 April 2015 / Victoria White

Bionomics has initiated a Phase II clinical study of BNC210, the Company’s drug candidate in development for the treatment of anxiety and depression…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +